NewHold Investment Corp IV (NHIV) Stock Analysis & Price (Updated Oct 15, 2026, 4:00 PM ET)
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $10.05, +0.00% vs the prior close of $10.05.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NHIV ends flat (+0.0%) to $10.05, 17 down days in a row. Closed at $10.05, +0.00% vs the prior close of $10.05. Day range $10.05–$10.05, opened at $10.05.
NHIV daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — NHIV ends flat (+0.0%) to $10.05, 17 down days in a row
- Closed at $10.05, +0.00% vs the prior close of $10.05. Day range $10.05–$10.05, opened at $10.05.
- Price is -0.4% vs its 50-day average ($10.09).
- 52-week range $9.80–$11.50; today's close sits at 15% of that range, 12.6% below the 52-week high.
- That makes 17 straight losses.
Oct 14, 2026 — NHIV ends flat (+0.0%) to $10.05 on 25.2x normal volume
- Closed at $10.05, +0.00% vs the prior close of $10.05. Day range $10.05–$10.05, opened at $10.05.
- Volume was 325.10K shares, 25.2x its 50-day average of 12.89K — unusually heavy trading.
- Price is -0.4% vs its 50-day average ($10.09).
- 52-week range $9.80–$11.50; today's close sits at 15% of that range, 12.6% below the 52-week high.
- That makes 16 straight losses.
Oct 13, 2026 — NHIV ends flat (+0.0%) to $10.05, 15 down days in a row
- Closed at $10.05, +0.00% vs the prior close of $10.05. Day range $10.05–$10.05, opened at $10.05.
- Volume was 3.20K shares, 0.2x its 50-day average of 12.85K — lighter than usual.
- Price is -0.4% vs its 50-day average ($10.09).
- 52-week range $9.80–$11.50; today's close sits at 15% of that range, 12.6% below the 52-week high.
- That makes 15 straight losses.
Oct 12, 2026 — NHIV ends flat (+0.0%) to $10.05, 14 down days in a row
- Closed at $10.05, +0.00% vs the prior close of $10.05. Day range $10.05–$10.05, opened at $10.05.
- Price is -0.4% vs its 50-day average ($10.09).
- 52-week range $9.80–$11.50; today's close sits at 15% of that range, 12.6% below the 52-week high.
- That makes 14 straight losses.
Oct 9, 2026 — NHIV ends flat (+0.0%) to $10.05, 13 down days in a row
- Closed at $10.05, +0.00% vs the prior close of $10.05. Day range $10.05–$10.05, opened at $10.05.
- Price is -0.4% vs its 50-day average ($10.10).
- 52-week range $9.80–$11.50; today's close sits at 15% of that range, 12.6% below the 52-week high.
- That makes 13 straight losses.
Oct 8, 2026 — NHIV ends flat (+0.0%) to $10.05, 12 down days in a row
- Closed at $10.05, +0.00% vs the prior close of $10.05. Day range $10.05–$10.05, opened at $10.05.
- Price is -0.5% vs its 50-day average ($10.10).
- 52-week range $9.80–$11.50; today's close sits at 15% of that range, 12.6% below the 52-week high.
- That makes 12 straight losses.
Oct 7, 2026 — NHIV ends flat (+0.0%) to $10.05, 11 down days in a row
- Closed at $10.05, +0.00% vs the prior close of $10.05. Day range $10.05–$10.05, opened at $10.05.
- Price is -0.5% vs its 50-day average ($10.10).
- 52-week range $9.80–$11.50; today's close sits at 15% of that range, 12.6% below the 52-week high.
- That makes 11 straight losses.
Oct 6, 2026 — NHIV ends flat (+0.0%) to $10.05, 10 down days in a row
- Closed at $10.05, +0.00% vs the prior close of $10.05. Day range $10.05–$10.05, opened at $10.05.
- Price is -0.5% vs its 50-day average ($10.10).
- 52-week range $9.80–$11.50; today's close sits at 15% of that range, 12.6% below the 52-week high.
- That makes 10 straight losses.
Oct 5, 2026 — NHIV ends flat (+0.0%) to $10.05, 9 down days in a row
- Closed at $10.05, +0.00% vs the prior close of $10.05. Day range $10.05–$10.05, opened at $10.05.
- Price is -0.5% vs its 50-day average ($10.10).
- 52-week range $9.80–$11.50; today's close sits at 15% of that range, 12.6% below the 52-week high.
- That makes 9 straight losses.
Oct 2, 2026 — NHIV ends flat (+0.0%) to $10.05, 8 down days in a row
- Closed at $10.05, +0.00% vs the prior close of $10.05. Day range $10.05–$10.05, opened at $10.05.
- Price is -0.5% vs its 50-day average ($10.10).
- 52-week range $9.80–$11.50; today's close sits at 15% of that range, 12.6% below the 52-week high.
- That makes 8 straight losses.
NHIV latest news & SEC filings
Every SEC filing by or about NHIV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 24, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $854.00K
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 21, 2026 · Form 10-Q/A — Quarterly report (amended)
Amended quarterly report
Quarter ended Mar 31, 2026:
- Net income: -$38.00K
Things to know before you trade NHIV
- How much it moves: over the last 20 sessions the average daily move was 0.11% (largest 1.1%). That is a relatively calm stock.
- Liquidity: about 37.60K shares (≈$377.88K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $10.05 vs a range of $9.80–$11.50 (15% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 14, 2026; 8-K Jul 22, 2026; 10-Q May 29, 2026.
- Listing: Nasdaq · industry: Blank Checks.
NHIV market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 0 |
| Oct 14, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 325.10K |
| Oct 13, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 3.20K |
| Oct 12, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 0 |
| Oct 9, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 0 |
| Oct 8, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 0 |
| Oct 7, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 0 |
| Oct 6, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 0 |
| Oct 5, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 0 |
| Oct 2, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 0 |
| Oct 1, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 75.10K |
| Sep 30, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 0 |
| Sep 29, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 500 |
| Sep 28, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 0 |
| Sep 25, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 600 |
| Sep 24, 2026 | 10.06 | 10.06 | 10.06 | 10.06 | 0 |
| Sep 23, 2026 | 10.06 | 10.06 | 10.06 | 10.06 | 335.00K |
| Sep 22, 2026 | 10.16 | 10.16 | 10.16 | 10.16 | 100 |
| Sep 21, 2026 | 10.05 | 10.05 | 10.05 | 10.05 | 1.00K |
| Sep 18, 2026 | 10.05 | 10.07 | 10.05 | 10.05 | 11.40K |
About NewHold Investment Corp IV
NewHold Investment Corp IV (NHIV) is listed on the Nasdaq and classified by the SEC under “Blank Checks”. Its business address is in NEW YORK, NY. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 2099767.
NHIV board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Charlie Baynes-Reid | Director | Apr 21, 2026 |
| Phil Horlock | Director | Apr 16, 2026 |
| Brian Mathis | Director | Apr 15, 2026 |
| Bryan Mikula | Director | Apr 15, 2026 |
| Scott Scharfman | Director | Apr 21, 2026 |
| Thomas J. Sullivan | Director | Apr 16, 2026 |
| Sezaneh Taherian | Director | Apr 16, 2026 |
| James Yerbic | Director | Apr 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John Anthony Boone | Chief Financial Officer | Aug 24, 2026 |
| Kevin M. Charlton | Chief Executive Officer | Apr 15, 2026 |
| Samy Hammad | President and COO | Apr 21, 2026 |
| Isobel Paola Schneck | Chief Financial Officer | Apr 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
NHIV financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $204.31M, total liabilities $7.44M, cash $1.33M (as of Jun 30, 2026).
NHIV earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Blank Checks
Southport Acquisition Corp. II (PORT-UN)Bold Eagle Acquisition (BEAG)Innventure (INV)Live Oak Acquisition Corp. VI (LOVIU)Pine Tree Acquisition (PAXGU)Frazier Life Sciences Acquisition Corp. II (FLSC)Archimedes Tech SPAC Partners II (ATII)Bluerock Acquisition Corp. II (BRRKU)EQV Ventures Acquisition Corp. II (EVAC)Pyrophyte Acquisition Corp. II (PAII)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NHIV
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.